3Hariraj R,Stoner E,Preston D M.Prolonged choestasis associated with Irbesatan.BMJ,2000,32l:547.
4Maillard J O,Descombes E,Fellay G,et al.Repeated transient anuria following Losartan administration in a patient with a solitary kidney.Renal Failure,2001,23(1):143-147.
5Lee H Y,Kim C H.Acute oliguric renal failure associated with angiotensin-II-receptor antagonists.American Journal of Medicine,2001,111(1):162-163.
6Schwarzbeck A,Withenrneier K W,Hallfrutzseh U.Anaemia in dialysis patients as a effect of sartans.Lancet,1998,9124:286.
9Chin A G,Krowiak E J,Deeb Z E.Angioedema associated with angiotensin-Ⅱ-receptor antagonists:challenging our knowledge of angioedema and its etiology.Laryngoscope,2001,111:1729-1731.
5[1]Devereux RB, Alons DR, Lutas EM, et al. Echocardiographic assessment of left ventricular hypertrophy comparision to necropsy finding.Am J Cardiol 1986;57:450
6[2]Devereux RB. Therapeutic options in minimizing left ventricular hypertrophy. Am Heart J, 2000,139
7[3]Califf RM, Cohn JN, Minm M. Cardiac protection: Evolving role of angiotensin receptor blockers. Am Heart J ,2000,139:15
8[1]Coca A, Calvo C, Carcia-Puig J, et al. A multicenter, randomized,double-blind comparison of the efficacy and safety of irbesartan and enalapril in adults with mild to moderate essential hypertension, as assesstial by by ambulatory blood pressure monitoring: the MAPAVEL Study[J]. Clin Ther, 2002,24(1):126.
9[2]Singh NP, Uppal M, Anuradha S, et al. Angiotensin converting enzyme inhibitors and cough--a north Indian study [J]. J Assoc Physicians Indian, 1998,46(5) :448.
10[3]Jackson EK, Garrison JC. Renin and angiotensin [A]. In: Hardman JG, Limbird LE, Molinoff PB, eds.Goodman & gilman' s the pharmacological basis of therapeutics[M]. 9 th. New York: McGraw Hill, 1996.733-758.
